{"id":2360,"date":"2018-06-05T08:28:59","date_gmt":"2018-06-05T08:28:59","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=2360"},"modified":"2018-06-05T08:28:59","modified_gmt":"2018-06-05T08:28:59","slug":"les-echos-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/les-echos-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash\/","title":{"rendered":"Les Echos &#8211; Enyo Pharma mobilise 40 millions contre l&#8217;h\u00e9patite B et la NASH"},"content":{"rendered":"<p><\/center><a href=\"https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/0301751138430-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash-2181141.php\" target=\"_blank\" rel=\"noopener\">https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/0301751138430-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash-2181141.php<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><a href=\"https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/0301751138430-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash-2181141.php\" target=\"_blank\" rel=\"noopener\">https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/0301751138430-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash-2181141.php<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[14],"tags":[],"class_list":["post-2360","post","type-post","status-publish","format-standard","hentry","category-media-coverage-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/media-coverage-fr\/\" rel=\"category tag\">Couverture m\u00e9diatique<\/a>","rttpg_excerpt":"https:\/\/www.lesechos.fr\/pme-regions\/innovateurs\/0301751138430-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash-2181141.php","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/2360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=2360"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/2360\/revisions"}],"predecessor-version":[{"id":2361,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/2360\/revisions\/2361"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=2360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=2360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=2360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}